These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 30659696)

  • 1. Contrast-enhanced MRI for breast cancer screening.
    Mann RM; Kuhl CK; Moy L
    J Magn Reson Imaging; 2019 Aug; 50(2):377-390. PubMed ID: 30659696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI breast screening revisited.
    Heller SL; Moy L
    J Magn Reson Imaging; 2019 May; 49(5):1212-1221. PubMed ID: 30693603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abbreviated MRI of the Breast: Does It Provide Value?
    Leithner D; Moy L; Morris EA; Marino MA; Helbich TH; Pinker K
    J Magn Reson Imaging; 2019 Jun; 49(7):e85-e100. PubMed ID: 30194749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast MRI screening for average-risk women: A monte carlo simulation cost-benefit analysis.
    Mango VL; Goel A; Mema E; Kwak E; Ha R
    J Magn Reson Imaging; 2019 Jun; 49(7):e216-e221. PubMed ID: 30632645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial.
    Saadatmand S; Geuzinge HA; Rutgers EJT; Mann RM; de Roy van Zuidewijn DBW; Zonderland HM; Tollenaar RAEM; Lobbes MBI; Ausems MGEM; van 't Riet M; Hooning MJ; Mares-Engelberts I; Luiten EJT; Heijnsdijk EAM; Verhoef C; Karssemeijer N; Oosterwijk JC; Obdeijn IM; de Koning HJ; Tilanus-Linthorst MMA;
    Lancet Oncol; 2019 Aug; 20(8):1136-1147. PubMed ID: 31221620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast Biopsy Intensity and Findings Following Breast Cancer Screening in Women With and Without a Personal History of Breast Cancer.
    Buist DSM; Abraham L; Lee CI; Lee JM; Lehman C; O'Meara ES; Stout NK; Henderson LM; Hill D; Wernli KJ; Haas JS; Tosteson ANA; Kerlikowske K; Onega T;
    JAMA Intern Med; 2018 Apr; 178(4):458-468. PubMed ID: 29435556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of breast MRI for patients with a biopsy showing atypical ductal hyperplasia (ADH).
    Tsuchiya K; Mori N; Schacht DV; Sheth D; Karczmar GS; Newstead GM; Abe H
    J Magn Reson Imaging; 2017 Dec; 46(6):1738-1747. PubMed ID: 28295791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the high breast cancer risk italian 1 study): final results.
    Sardanelli F; Podo F; Santoro F; Manoukian S; Bergonzi S; Trecate G; Vergnaghi D; Federico M; Cortesi L; Corcione S; Morassut S; Di Maggio C; Cilotti A; Martincich L; Calabrese M; Zuiani C; Preda L; Bonanni B; Carbonaro LA; Contegiacomo A; Panizza P; Di Cesare E; Savarese A; Crecco M; Turchetti D; Tonutti M; Belli P; Maschio AD;
    Invest Radiol; 2011 Feb; 46(2):94-105. PubMed ID: 21139507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI.
    Vreemann S; van Zelst JCM; Schlooz-Vries M; Bult P; Hoogerbrugge N; Karssemeijer N; Gubern-Mérida A; Mann RM
    Breast Cancer Res; 2018 Aug; 20(1):84. PubMed ID: 30075794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supplemental Screening for Patients at Intermediate and High Risk for Breast Cancer.
    Wang L; Strigel RM
    Radiol Clin North Am; 2021 Jan; 59(1):67-83. PubMed ID: 33223001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic sensitivity of dynamic contrast-enhanced magnetic resonance imaging and breast-specific gamma imaging in women with calcified and non-calcified DCIS.
    Kim JS; Lee SM; Cha ES
    Acta Radiol; 2014 Jul; 55(6):668-75. PubMed ID: 24043881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supplemental Breast MR Imaging Screening of Women with Average Risk of Breast Cancer.
    Kuhl CK; Strobel K; Bieling H; Leutner C; Schild HH; Schrading S
    Radiology; 2017 May; 283(2):361-370. PubMed ID: 28221097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of gadobenate dimeglumine-enhanced breast MRI and gadopentetate dimeglumine-enhanced breast MRI with mammography and ultrasound for the detection of breast cancer.
    Gilbert FJ; van den Bosch HC; Petrillo A; Siegmann K; Heverhagen JT; Panizza P; Gehl HB; Pediconi F; Diekmann F; Peng WJ; Ma L; Sardanelli F; Belli P; Corcione S; Zechmann CM; Faivre-Pierret M; Martincich L
    J Magn Reson Imaging; 2014 May; 39(5):1272-86. PubMed ID: 25006633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interval Cancers after Negative Supplemental Screening Breast MRI Results in Women with a Personal History of Breast Cancer.
    Kim GR; Cho N; Kim SY; Han W; Moon WK
    Radiology; 2021 Aug; 300(2):314-323. PubMed ID: 34100684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of abbreviated breast MRI screening for women with a history of breast cancer surgery.
    Choi BH; Choi N; Kim MY; Yang JH; Yoo YB; Jung HK
    Breast Cancer Res Treat; 2018 Jan; 167(2):495-502. PubMed ID: 29030785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI of the breast as part of the assessment in population-based mammography screening.
    Bick U; Engelken F; Diederichs G; Dzyuballa R; Ortmann M; Fallenberg EM
    Rofo; 2013 Sep; 185(9):849-56. PubMed ID: 23740312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer.
    Kuhl CK; Schrading S; Leutner CC; Morakkabati-Spitz N; Wardelmann E; Fimmers R; Kuhn W; Schild HH
    J Clin Oncol; 2005 Nov; 23(33):8469-76. PubMed ID: 16293877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density.
    Riedl CC; Luft N; Bernhart C; Weber M; Bernathova M; Tea MK; Rudas M; Singer CF; Helbich TH
    J Clin Oncol; 2015 Apr; 33(10):1128-35. PubMed ID: 25713430
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 28.